Skip to main content
logo
Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
19.93
-0.14 (-0.70%)
At close: Aug 13, 2026, 4:00 PM EDT
19.99
+0.06 (0.30%)
Pre-market: Aug 14, 2026, 6:01 AM EDT

Relay Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-286.04-276.48-337.71-341.97-290.51-363.87
Depreciation & Amortization
2.213.565.465.274.133.93
Stock-Based Compensation
48.3162.4294.1486.0356.1448.45
Other Adjustments
-3.01-1.65-25.62-17.19-10.5139.74
Change in Receivables
-1.61-5.22-0.2877.79
Changes in Accounts Payable
17.15-11.4410.27-9.5911.290.93
Changes in Accrued Expenses
-----21
Changes in Unearned Revenue
--7.687.68--0.25-
Changes in Other Operating Activities
7.69-5.64-2.35-29.220.48-2.38
Operating Cash Flow
-212.21-235.46-249.11-300.32-229.49-74.41
Operating Cash Flow Growth
------
Capital Expenditures
--0.41-2.02-4.13-9.06-3.47
Purchases of Investments
-614.3-122.97-650.63-385.54-535.42-980.67
Proceeds from Sale of Investments
369.36316.18611.56647.3355.74529.92
Cash Acquisitions
------25.3
Investing Cash Flow
-244.94192.8-41.08257.63-188.75-479.51
Issuance of Common Stock
166.651.6270.1534.75289.91388.09
Net Common Stock Issued (Repurchased)
166.651.6270.1534.75289.91388.09
Financing Cash Flow
463.471.6270.1534.75289.91388.09
Net Cash Flow
6.33-41.05-20.04-7.93-128.33-165.83
Free Cash Flow
-212.21-235.87-251.13-304.44-238.55-77.88
Free Cash Flow Growth
------
FCF Margin
-2050.29%-1536.08%-2509.49%-1191.74%-17273.90%-2571.05%
Free Cash Flow Per Share
-1.17-1.37-1.76-2.48-2.13-0.82
Levered Free Cash Flow
-258.99-298.09-318.67-379.64-283.92-343.87
Unlevered Free Cash Flow
-283.39-324.35-353.43-410.67-292.68-344.69
SEC Filings: 10-K · 10-Q